Skip to main content
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
- Bowtell, David D;
- Böhm, Steffen;
- Ahmed, Ahmed A;
- Aspuria, Paul-Joseph;
- Bast, Robert C;
- Beral, Valerie;
- Berek, Jonathan S;
- Birrer, Michael J;
- Blagden, Sarah;
- Bookman, Michael A;
- Brenton, James D;
- Chiappinelli, Katherine B;
- Martins, Filipe Correia;
- Coukos, George;
- Drapkin, Ronny;
- Edmondson, Richard;
- Fotopoulou, Christina;
- Gabra, Hani;
- Galon, Jérôme;
- Gourley, Charlie;
- Heong, Valerie;
- Huntsman, David G;
- Iwanicki, Marcin;
- Karlan, Beth Y;
- Kaye, Allyson;
- Lengyel, Ernst;
- Levine, Douglas A;
- Lu, Karen H;
- McNeish, Iain A;
- Menon, Usha;
- Narod, Steven A;
- Nelson, Brad H;
- Nephew, Kenneth P;
- Pharoah, Paul;
- Powell, Daniel J;
- Ramos, Pilar;
- Romero, Iris L;
- Scott, Clare L;
- Sood, Anil K;
- Stronach, Euan A;
- Balkwill, Frances R
- et al.
Published Web Location
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892184/pdf/nihms787460.pdfNo data is associated with this publication.
Abstract
High-grade serous ovarian cancer (HGSOC) accounts for 70-80% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. In this Opinion article, we outline a set of research priorities that we believe will reduce incidence and improve outcomes for women with this disease. This 'roadmap' for HGSOC was determined after extensive discussions at an Ovarian Cancer Action meeting in January 2015.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.